• News
  • SAN DIEGO
  • BioTech

International Stem Cell Corp. revenues up 35%

International Stem Cell Corp. (OTC: ISCO), a Carlsbad-based biotechnology company developing novel stem cell-based therapies and biomedical products, Tuesday provided a business update and announced fourth quarter and year-end financial results for the year ended Dec. 31, 2013.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

International Stem Cell Corp.

Company Website

5950 Priestly Dr.
Carlsbad, CA 92008

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ISCO
0.07
  0.00  
+ 0.00%
1,237,692,000
0.28
0.06

International Stem Cell Corp. Executive(s):

Andrey Semechkin

  • Chief Executive Officer
Subscribe Today!